Please login to the form below

Not currently logged in
Email:
Password:

payers

This page shows the latest payers news and features for those working in and with pharma, biotech and healthcare.

OPEN Health scoops up Medical Affairs Agency Award at Communiqué 2020

OPEN Health scoops up Medical Affairs Agency Award at Communiqué 2020

The category was open to any agency focused on delivering scientific programmes with medical affairs personnel within pharmaceutical companies, med tech and biotech aimed at the healthcare professional, payer or patients.

Latest news

More from news
Approximately 5 fully matching, plus 579 partially matching documents found.

Latest Intelligence

  • The impact of COVID-19 on clinical trials The impact of COVID-19 on clinical trials

    In addition, shifting priorities in health spending may decrease payers’ willingness to reimburse for some products and put new levels of pricing (and thus further revenue) pressure on companies.

  • Addressing the payer-regulator evidence gap in early-stage cancer Addressing the payer-regulator evidence gap in early-stage cancer

    Payers may be more uncertain in the use of these endpoints to assign value to new oncology therapies. ... A more flexible approach may be needed where payer uncertainty on the quantity and value of benefit remains.

  • Things are going to be different Things are going to be different

    Combining this with first-hand feedback from healthcare professionals, payers, providers and patients across countries and therapy areas delivers unique global insight that, in turn, will help identify the critical success

  • The big issue The big issue

    macrocongruence). They said the same things about change in the sociological environment, such as payer systems, epidemiological shifts and demographic trends (that is, it is hard to maintain sociological macrocongruence).

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    Long-term sustainability. Deals must be win-win because it is important to create a true long-term partnership between payers and industry. ... Payers must positively want to use new treatments and industry must feel its investment is rewarded.

More from intelligence
Approximately 5 fully matching, plus 235 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 14 fully matching, plus 135 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics